Infant, children’s Tylenol, Motrin recalled in U.S.

WASHINGTON, May 1 (BestGrowthStock) – The U.S. Food and Drug
Administration on Saturday urged consumers to stop using liquid
Tylenol, Motrin, Benadryl and Zyrtec medicines for children and
infants after a broad recall announced by the manufacturer,
although it said the chance of serious problems was remote.

Johnson & Johnson’s (JNJ.N: ) consumer division announced a
broad recall of products, including certain liquid infant’s and
children’s Tylenol, Motrin, Zyrtec, and Benadryl products late
on Friday.

A full list of affected products made by McNeil Consumer
Healthcare is available at
http://www.mcneilproductrecall.com

“We want to be certain that consumers discontinue using
these products,” FDA Commissioner Margaret Hamburg said in a
statement.

“While the potential for serious health problems is remote,
Americans deserve medications that are safe, effective and of
the highest quality. We are investigating the products and
facilities associated with this recall and will provide updates
as we learn more,” she said.

McNeil said it was recalling the products in consultation
with the FDA after discovering manufacturing deficiencies that
could affect the quality, purity or potency of the medicines.

The FDA said some of the products may not meet required
quality standards, and parents and caregivers should stop
administering them to children and switch to generic brands,
which are not affected by the recall.

They said consumers should not administer adult strength
medicine to infants or children since that could result in
serious harm.

Some of the products affected by the recall may contain a
higher concentration of active ingredient than specified;
others contain inactive ingredients that may not meet internal
testing requirements; and others may contain tiny particles,
the FDA said.

The FDA said the chance of an adverse reaction was remote,
but urged consumers to contact their doctors and the FDA if
their children exhibited any symptoms.

Stock Report

(Reporting by Andrea Shalal-Esa; Editing by Eric Beech)

Infant, children’s Tylenol, Motrin recalled in U.S.